MedTrace Logo

Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

NCT03532854 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2019-02-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the drug-drug interaction between LGEV1801 and LGEV1802 in healthy male volunteers.

Conditions

  • Healthy Male Volunteers

Interventions

DRUG

Valsartan

Valsartan P.O

DRUG

Ezetimibe/Rosuvastatin

Ezetimibe/Rosuvastatin P.O

Sponsors & Collaborators

  • LG Chem

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-28
Primary Completion
2018-08-25
Completion
2019-01-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03532854 on ClinicalTrials.gov